XANADU BIO
Live / Allowed — Notice of allowance issued (as of 15 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99657815
- Mark type
- Stylized text
- Filed
- 18 Feb 2026
- Published for opposition
- 21 Jul 2026
- Attorney of record
- Rachelle A. Dubow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely antivirals; Pharmaceutical products for the treatment of viral and infectious diseases; Pharmaceutical products for the treatment of cancer; pharmaceutical preparations, namely, vaccines; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer nanoparticles for the release of a wide variety of therapeutic agents
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Xanadu Bio, Inc., Gladwyne, PA, US
- Xanadu Bio, Inc., Gladwyne, PA, US
Prosecution history
- 15 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jun 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 23 Jun 2026 — EXAMINER'S AMENDMENT ENTERED
- 23 Jun 2026 — EXAMINERS AMENDMENT E-MAILED
- 23 Jun 2026 — EXAMINERS AMENDMENT -WRITTEN
- 22 Jun 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Jun 2026 — NON-FINAL ACTION E-MAILED
- 22 Jun 2026 — NON-FINAL ACTION WRITTEN
- 17 Jun 2026 — ASSIGNED TO EXAMINER
- 16 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Feb 2026 — APPLICATION FILING RECEIPT MAILED